Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version).
10.3760/cma.j.cn112151-20241120-00770
- Collective Name:Chinese Society of Pathology;Pathology Expert Committee of Chinese Society of Clinical Oncology;Pathology Quality Control Center
- Publication Type:Practice Guideline
- MeSH:
Humans;
Class I Phosphatidylinositol 3-Kinases/genetics*;
Breast Neoplasms/diagnosis*;
Mutation;
Female;
China;
DNA Mutational Analysis/methods*;
Genetic Testing/standards*
- From:
Chinese Journal of Pathology
2025;54(2):120-125
- CountryChina
- Language:Chinese
